By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



204 2nd Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


Medical Device

Company News
Augmenix Announces The Publication Of The Spaceoar Hydrogel Pivotal Clinical Study Results: Application Technique And Patient Tolerance In Men Undergoing Prostate Cancer Radiotherapy 3/31/2016 10:58:31 AM
Augmenix’ SpaceOAR System Experiences Rapid U.S. Adoption 10/15/2015 11:09:31 AM
Augmenix Announces Publication Of Spaceoar System Clinical Trial Results In Leading Radiation Oncology Journal 6/11/2015 8:51:19 AM
Augmenix Announces FDA Clearance Of SpaceOAR System 4/2/2015 9:02:04 AM
Massachusett's Augmenix $10.8 Million Series D 7/24/2014 6:53:24 AM
Augmenix Receives FDA Clearance to Market Its TraceIT™ Tissue Marker 1/28/2013 7:01:58 AM
Varian Medical Systems (VAR) Makes $15 Million Equity Investment and Obtains Option to Purchase Augmenix 5/12/2011 6:36:07 AM
Augmenix Announces First Commercial Use of SpaceOAR(TM) System for Prostate-Rectum Separation in Prostate Cancer Patients Undergoing Radiation Therapy 8/12/2010 8:20:11 AM
Augmenix Closes $6.1 Million Financing 10/19/2009 7:03:38 AM
Medical Device Developer Augmenix Raises $4.7 Million 7/24/2009 7:19:31 AM